Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019

SELL
$44.62 - $49.34 $17,401 - $19,242
-390 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $17,100 - $20,390
-379 Reduced 49.28%
390 $19,000
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $4,749 - $5,920
-94 Reduced 10.89%
769 $43,000
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $2,996 - $3,449
-50 Reduced 5.48%
863 $55,000
Q4 2017

Feb 02, 2018

BUY
$59.94 - $65.35 $13,846 - $15,095
231 Added 33.87%
913 $56,000
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $10,935 - $12,620
-198 Reduced 22.5%
682 $43,000
Q2 2017

Aug 10, 2017

BUY
N/A
880
880 $49,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Omnia Family Wealth, LLC Portfolio

Follow Omnia Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omnia Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omnia Family Wealth, LLC with notifications on news.